Shares of Butterfly Network Inc (NYSE: BFLY) surged 10.72% in pre-market trading on Friday, following the company's better-than-expected fourth quarter 2024 earnings and record quarterly revenue.
The medical imaging technology company reported Q4 2024 revenue of $22.4 million, up 35% year-over-year, beating analyst estimates. This was driven by strong product sales growth of 45% and a higher selling price for its next-generation iQ3 ultrasound probe. Butterfly also reduced its Q4 net loss by 59% and net cash used in operations by a significant 76%.
For fiscal 2024, Butterfly delivered 25% topline growth and achieved key milestones across its core ultrasound and AI-powered software businesses. With a successful $81.7 million capital raise in January 2025, the company is well-positioned to invest in growth initiatives while maintaining a path to cash flow independence.
Butterfly provided upbeat 2025 revenue guidance of $96-$100 million, representing approximately 20% growth, backed by accelerating demand for its innovative ultrasound solutions. The strong financial performance and positive outlook signaled continued execution on Butterfly's vision of making advanced medical imaging more accessible globally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.